These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Serum levels and peritoneal loss of prolactin in CAPD patients. Kagan A; Gertler A; Ulman M; Bar-Khayim Y Adv Perit Dial; 1991; 7():247-52. PubMed ID: 1680437 [TBL] [Abstract][Full Text] [Related]
27. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis. Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391 [TBL] [Abstract][Full Text] [Related]
28. Serum CA-125 level in end-stage renal disease patients maintained on chronic peritoneal dialysis or hemodialysis: the effect of continuous presence of peritoneal fluid, peritonitis, and peritoneal catheter implantation. Bastani B; Chu N Am J Nephrol; 1995; 15(6):468-72. PubMed ID: 8546167 [TBL] [Abstract][Full Text] [Related]
30. The effect of renal replacement therapies on serum gastrointestinal system hormones. Borazan A; Cavdar Z; Saglam F Ren Fail; 2007; 29(8):1019-23. PubMed ID: 18067050 [TBL] [Abstract][Full Text] [Related]
31. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis]. Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852 [TBL] [Abstract][Full Text] [Related]
32. Influenza antibody titers after vaccination of chronic renal failure patients; before and during hemodialysis, or on continuous ambulatory peritoneal dialysis. Suga T; Niki H; Niikura M; Matsumoto Y; Nishimura T; Nakajima K; Miyazaki M; Endoh M; Nomoto Y; Sakai H Tokai J Exp Clin Med; 1990 May; 15(2-3):245-51. PubMed ID: 2130531 [TBL] [Abstract][Full Text] [Related]
33. Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: a prospective study. So JB; Yeoh KG; Moochala S; Chachlani N; Ho J; Wong WK; Mack P; Goh PM Gastric Cancer; 2002; 5(4):228-32. PubMed ID: 12491081 [TBL] [Abstract][Full Text] [Related]
34. In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Pereira BJ; Poutsiaka DD; King AJ; Strom JA; Narayan G; Levey AS; Dinarello CA Kidney Int; 1992 Dec; 42(6):1419-24. PubMed ID: 1474775 [TBL] [Abstract][Full Text] [Related]
35. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease. Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268 [TBL] [Abstract][Full Text] [Related]
36. Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis. Shusterman NH; Wasserstein AG; Morrison G; Audet P; Fallon MD; Kaplan F Am J Med; 1987 Jun; 82(6):1148-56. PubMed ID: 3605132 [TBL] [Abstract][Full Text] [Related]
37. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088 [TBL] [Abstract][Full Text] [Related]
38. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis. Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702 [TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up of patients treated with a combination of continuous ambulatory peritoneal dialysis and hemodialysis. Hoshi H; Nakamoto H; Kanno Y; Takane H; Ikeda N; Sugahara S; Okada H; Suzuki H Adv Perit Dial; 2006; 22():136-40. PubMed ID: 16983957 [TBL] [Abstract][Full Text] [Related]
40. Heme synthesis in chronic renal failure: the effects of hemodialysis, peritoneal dialysis and erythropoietin treatment. Siersema PD; de Rooij FW; Edixhoven-Bosdijk A; Weimar W; Wilson JH Nephron; 1995; 71(3):297-302. PubMed ID: 8569978 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]